###begin article-title 0
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Nicotinamide Riboside Kinase Structures Reveal New Pathways to NAD+
###end article-title 0
###begin p 1
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 950 951 950 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1146 1147 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 142 147 <span type="species:ncbi:4932">yeast</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 523 528 <span type="species:ncbi:9606">human</span>
###xml 848 853 <span type="species:ncbi:9606">human</span>
###xml 885 890 <span type="species:ncbi:4932">yeast</span>
The eukaryotic nicotinamide riboside kinase (Nrk) pathway, which is induced in response to nerve damage and promotes replicative life span in yeast, converts nicotinamide riboside to nicotinamide adenine dinucleotide (NAD+) by phosphorylation and adenylylation. Crystal structures of human Nrk1 bound to nucleoside and nucleotide substrates and products revealed an enzyme structurally similar to Rossmann fold metabolite kinases and allowed the identification of active site residues, which were shown to be essential for human Nrk1 and Nrk2 activity in vivo. Although the structures account for the 500-fold discrimination between nicotinamide riboside and pyrimidine nucleosides, no enzyme feature was identified to recognize the distinctive carboxamide group of nicotinamide riboside. Indeed, nicotinic acid riboside is a specific substrate of human Nrk enzymes and is utilized in yeast in a novel biosynthetic pathway that depends on Nrk and NAD+ synthetase. Additionally, nicotinic acid riboside is utilized in vivo by Urh1, Pnp1, and Preiss-Handler salvage. Thus, crystal structures of Nrk1 led to the identification of new pathways to NAD+.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1168 1169 1168 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1339 1340 1339 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1393 1394 1393 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 365 370 <span type="species:ncbi:4932">yeast</span>
###xml 608 613 <span type="species:ncbi:9606">human</span>
###xml 731 736 <span type="species:ncbi:4932">yeast</span>
###xml 819 824 <span type="species:ncbi:9606">human</span>
###xml 1022 1027 <span type="species:ncbi:9606">human</span>
###xml 1227 1232 <span type="species:ncbi:4932">yeast</span>
###xml 1277 1282 <span type="species:ncbi:9606">human</span>
Biosynthesis of nicotinamide adenine dinucleotide (NAD+) is fundamental to cells, because NAD+ is an essential co-factor for metabolic and gene regulatory pathways that control life and death. Two vitamin precursors of NAD+ were discovered in 1938. We recently discovered nicotinamide riboside (NR) as a third vitamin precursor of NAD+ in eukaryotes, which extends yeast life span without caloric restriction and protects damaged dorsal root ganglion neurons from degeneration. Biosynthesis of NAD+ from NR requires enzyme activities in either of two pathways. In one pathway, specific NR kinases, including human Nrk1 and Nrk2, phosphorylate NR to nicotinamide mononucleotide. A second and Nrk-independent pathway is initiated by yeast nucleoside-splitting enzymes, Urh1 and Pnp1. We solved five crystal structures of human Nrk1 and, on the basis of co-crystal structures with substrates, suggested that the enzyme might be able to phosphorylate a novel compound, nicotinic acid riboside (NaR). We then demonstrated that human Nrk enzymes have dual specificity as NR/NaR kinases in vitro, and we established the ability of NaR to be used as a vitamin precursor of NAD+ via pathways initiated by Nrk1, Urh1, and Pnp1 in living yeast cells. Thus, starting from the structure of human Nrk1, we discovered a synthetic vitamin precursor of NAD+ and suggest the possibility that NaR is a normal NAD+ metabolite.
###end p 4
###begin p 5
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Eukaryotic nicotinamide riboside kinase (Nrk) converts nicotinamide riboside to NAD+ by phosphorylation and adenylylation. The structures of this enzyme bound to several substrates lead to identification of new pathways to NAD+
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b001">1</xref>
###xml 228 229 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b002">2</xref>
###xml 360 361 360 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b003">3</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 462 463 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b005">5</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b009">9</xref>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b010">10</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b012">12</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b013">13</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b014">14</xref>
###xml 718 719 718 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b001">1</xref>
NAD+ functions both as a co-enzyme for hydride transfer reactions and as a substrate for NAD+-consuming enzymes including Sirtuins and poly(ADPribose) polymerases [1]. Most fungal and animal cells have redundant pathways for NAD+ biosynthesis that consist of a de novo pathway from tryptophan [2] and salvage pathways that utilize the vitamin precursors of NAD+, namely nicotinic acid (Na), nicotinamide (Nam) [3], and nicotinamide riboside (NR) [4]. Because NAD+ biosynthesis is required for the function of Sirtuins [5-9] and given the evidence that Sirtuins play roles in life span extension [10-12], increased mitochondrial function [13], and energy expenditure [14], there has been a resurgence of interest in NAD+-boosting drug therapies and nutritional interventions [1].
###end p 7
###begin p 8
###xml 39 40 39 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK1</italic>
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK2</italic>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 125 130 <span type="species:ncbi:4932">yeast</span>
###xml 287 292 <span type="species:ncbi:4932">yeast</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 321 326 <span type="species:ncbi:9606">human</span>
###xml 427 432 <span type="species:ncbi:4932">yeast</span>
###xml 682 687 <span type="species:ncbi:4932">yeast</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 793 798 <span type="species:ncbi:9606">human</span>
NR, a natural product present in milk [4], increases NAD+ biosynthesis, increases Sir2-dependent gene silencing, and extends yeast life span via two NR salvage pathways [15]. The first NR salvage pathway depends on NR phosphorylation by a specific kinase, encoded by the products of the yeast and human NRK1 genes or the human NRK2 gene [4]. The second NR salvage pathway is Nrk-independent and is initiated by the activity of yeast Urh1, Pnp1 , and, to a slight degree, Meu1, which split NR into a ribosyl product and Nam for resynthesis of NAD+ via Nam salvage [15]. Although the second pathway of NR salvage has yet to be investigated in mammalian systems, Pnp1 and Meu1 are the yeast homologs of human purine nucleoside phosphorylase and methylthioadenosine phosphorylase, suggesting that human NR salvage may depend on Nrk1, Nrk2, and Pnp [15].
###end p 8
###begin p 9
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b016">16</xref>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b017">17</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b018">18</xref>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK2</italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b016">16</xref>
###xml 62 68 <span type="species:ncbi:10090">murine</span>
Na, Nam, and NR have been investigated in an ex vivo model of murine dorsal root ganglion neurodegeneration [16]. Prompted by genetic evidence that increased neuronal NAD+ biosynthesis protects against Wallerian degeneration [17,18], NR was shown to be the only NAD+ precursor vitamin that protects against axonopathy without engineered overexpression of a biosynthetic gene, apparently because the NRK2 gene is transcriptionally induced by nerve damage [16].
###end p 9
###begin p 10
###xml 100 102 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b019">19</xref>
###xml 108 124 96 112 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 146 148 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b020">20</xref>
###xml 227 251 215 239 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Saccharomyces cerevisiae</named-content>
###xml 272 276 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QNS1</italic>
###xml 315 316 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 331 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b021">21</xref>
###xml 399 400 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 470 471 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 573 575 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b022">22</xref>
###xml 610 611 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 108 124 <span type="species:ncbi:562">Escherichia coli</span>
###xml 169 174 <span type="species:ncbi:4932">yeast</span>
###xml 227 251 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
NR kinases are approximately200-amino acid polypeptides related to human uridine/cytidine kinase 2 [19] and Escherichia coli pantothenate kinase [20]. To establish that yeast Nrk1 and no other enzyme phosphorylates NR in vivo, Saccharomyces cerevisiae mutants without the QNS1 gene, encoding glutamine-dependent NAD+ synthetase [21] were shown to be entirely dependent on NR and Nrk1 for viability [4]. The human homologs Nrk1 and Nrk2 were validated in the same assay [4]. The presence of a human Nrk pathway suggests the means by which the anticancer prodrug tiazofurin [22] may be converted to the toxic NAD+ antagonist tiazofurin adenine dinucleotide (TAD).
###end p 10
###begin p 11
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 500 501 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 501 504 501 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 504 506 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/K</italic>
###xml 506 507 506 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 835 837 835 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1006 1008 1006 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1780 1781 1773 1774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2030 2031 2023 2024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9 14 <span type="species:ncbi:4932">yeast</span>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
###xml 977 982 <span type="species:ncbi:9606">human</span>
###xml 1810 1815 <span type="species:ncbi:4932">yeast</span>
Although yeast and human Nrk1 and human Nrk2 were purified and characterized with respect to NR, cytidine, uridine, and tiazofurin phosphorylation in specific activity terms [4], the kinetics of nucleoside and nucleoside triphosphate specificity have not been carefully quantified. Here we report the structure-activity relationships for human NR kinases with nucleoside and nucleoside triphosphate substrates. Nrk1 and Nrk2 both strongly discriminate against cytidine phosphorylation by 500-fold in kcat/KM. However, Nrk1 effectively phosphorylates NR with ATP or GTP and discriminates against uridine, whereas Nrk2 discriminates against GTP as a phosphodonor but does not strongly discriminate against phosphorylation of uridine. To dissect the structural basis for specificity, we crystallized selenomethionyl human Nrk1 bound to Mg2+.ADP and solved the 1.95 A structure of the Nrk1 monomer by single-wavelength anomalous scattering. Using a series of crystal structures of human Nrk1 bound to NR, NR.Mg2+.adenosine-5'-[(beta,gamma)-imido]triphosphate (AppNHp), and nicotinamide mononucleotide (NMN), we resolved snapshots of the catalytic cycle and identified two conserved carboxylate groups that we establish as essential for biological activity. From a structure of Nrk1 bound to tiazofurin, we gained further understanding of nucleoside specificity. However, at the site where we expected to find specific enzyme features that would recognize the distinctive carboxamide portion of NR and tiazofurin substrates, we found only steric complementarity and solvent exposure. Accordingly, we synthesized nicotinic acid riboside (NaR) and found this molecule to be as specific a biochemical substrate as is NR. Finally, we showed that NaR is a synthetic vitamin precursor of NAD+ that supports the growth of yeast cells through each of the salvage pathways-Nrk and Urh1/Pnp1-also used by NR. Thus, NR kinases are actually dual-specificity salvage enzymes that may play a role in another unanticipated biosynthetic pathway to NAD+.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Substrate Specificity of Recombinant Nrk1 and Nrk2
###end title 13
###begin p 14
###xml 86 93 86 93 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 270 273 270 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 296 298 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 348 351 348 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 589 590 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 590 593 578 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 594 595 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 595 596 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 648 649 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 705 706 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 706 709 694 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 710 711 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 711 712 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 722 724 710 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 725 727 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 807 809 795 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 810 812 798 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 869 871 857 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 872 874 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 892 894 880 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 895 897 883 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 86 93 <span type="species:ncbi:562">E. coli</span>
To assess Nrk specificity in vitro, recombinant human Nrk1 and Nrk2 were expressed in E. coli and purified by immobilized metal chelate affinity chromatography. As shown in Table 1, the enzymes discriminate between substrates almost entirely in the KM term. Nrk1 has a kcat of approximately 0.5 s-1 irrespective of substrate, and Nrk2 possesses a kcat of approximately 1 s-1 irrespective of substrate. Nrk1 strongly favors NR as a substrate, displaying a 340-fold preference for NR over cytidine in the KM term and a approximately500-fold preference over either cytidine or uridine in the kcat/KM term. Tiazofurin, the prodrug form of the toxic NAD+ analog TAD, is a relatively good Nrk1 substrate with a kcat/KM of 1300 s-1M-1, which represents 19% of the second-order rate for NR conversion to NMN (6800 s-1M-1). Moreover, Nrk1 shows little preference for ATP (6800 s-1M-1) over GTP (5000 s-1M-1) as phosphodonor in formation of NMN.
###end p 14
###begin p 15
###xml 25 30 <span type="species:ncbi:9606">Human</span>
Substrate Specificity of Human Nicotinamide Riboside Kinases
###end p 15
###begin p 16
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 308 310 308 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 351 353 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 354 356 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 377 379 377 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 380 382 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b019">19</xref>
Whereas these data would classify Nrk1 as an NR and tiazofurin:ATP or GTP kinase, the data establish Nrk2 as an ATP-specific NR, tiazofurin, and uridine kinase. As shown in Table 1, with GTP as the phosphodonor, Nrk2 has only 1.5% of the NR phosphorylating activity with respect to ATP. Tiazofurin (4500 s-1M-1) is phosphorylated as well as NR (3900 s-1M-1), and uridine (850 s-1M-1) is within 5-fold of NR. The fact that Nrk1 and Nrk2 are distinct from uridine/cytidine kinases [19] is underscored by the poor cytidine monophosphate-forming activity of each enzyme.
###end p 16
###begin title 17
Structural Basis of Substrate Specificity
###end title 17
###begin p 18
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 343 350 343 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t002">Table 2</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b023">23</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b024">24</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b025">25</xref>
###xml 669 671 669 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 729 730 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
To understand the basis for substrate specificity of human Nrk1, we prepared a selenomethionyl form of human Nrk1 and grew single crystals of a complex of the enzyme with Mg2+.ADP. A crystal, which had the symmetry of C2221, was subjected to 0.9793-A synchrotron X-radiation, and produced nearly complete diffraction data to 1.9-A resolution (Table 2). Single-wavelength anomalous scattering [23] allowed location of Se sites [24] and phasing [25] to produce an interpretable experimental electron density map of the Nrk1 monomer prior to model building. The 1.95-A refined protein model includes residues 1-82 and 92-189 of the 199-amino acid polypeptide, plus ADP, Mg2+, and 72 water molecules with B factors between 9 and 37 A2.
###end p 18
###begin p 19
Crystallization, Data Collection, and Refinement
###end p 19
###begin p 20
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g001">Figure 1</xref>
###xml 393 394 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 530 532 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b026">26</xref>
###xml 683 685 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b027">27</xref>
###xml 688 695 681 688 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 722 724 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b020">20</xref>
###xml 727 754 720 747 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Bacillus stearothermophilus</named-content>
###xml 773 775 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b028">28</xref>
###xml 781 788 774 781 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 807 809 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b029">29</xref>
###xml 871 879 864 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g001">Figure 1</xref>
###xml 645 650 <span type="species:ncbi:9606">human</span>
###xml 688 695 <span type="species:ncbi:562">E. coli</span>
###xml 727 754 <span type="species:ncbi:1422">Bacillus stearothermophilus</span>
###xml 781 788 <span type="species:ncbi:562">E. coli</span>
As shown in Figure 1A, Nrk1 consists of a five-stranded beta sheet flanked on one side by alpha helices, E and A, and on the other side by helix B. Additionally, the monomeric enzyme contains a lid domain consisting of helix C and D connected by a 12- amino acid loop. The five-stranded sheet is entirely parallel and is formed from strands 2, 3, 1, 4, and 5 in the primary sequence. Earlier [4], we detected sequence similarity with uridine/cytidine kinase and pantothenate kinase. Indeed, the DALI structural similarity server [26] revealed Nrk1 to be a structural homolog of a variety of Rossmann fold-containing metabolite kinases including human uridine/cytidine kinase 2 Uck2 [27], E. coli pantothenate kinase panK [20], Bacillus stearothermophilus adenylate kinase [28] and E. coli gluconate kinase [29]. A structural superposition of Nrk1 and Uck2 is provided in Figure 1B.
###end p 20
###begin title 21
Nrk1 Is a Rossmann Fold Metabolite Kinase
###end title 21
###begin p 22
###xml 241 246 <span type="species:ncbi:9606">human</span>
(A) Ribbon diagram of Nrk1 bound to ADP with rainbow coloring from the N terminus (violet) to the C terminus (red). Helices A through E, strands 1 through 5, and the lid domain are indicated. (B) Structural superposition of Nrk1 (blue) with human Uck2 (red).
###end p 22
###begin p 23
###xml 40 42 40 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b030">30</xref>
###xml 127 135 127 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
###xml 903 905 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b031">31</xref>
The ADP-binding site, including P-loop [30] sequence Gly-Val-Thr-Asn-Ser-Gly-Lys-Thr (residues 10-17), is shown in close-up in Figure 2A. The guanidino group of Arg132, the epsilon amino group of Lys16, and the hydroxyl of Thr18 coordinate the beta and alpha phosphates of ADP, whereas the hydroxyl of Thr17, a beta phosphate oxygen, and four well-ordered water molecules coordinate the magnesium ion. The adenine ring of ADP lies between Arg128 and Glu174. Accounting for the ATP/GTP nonspecificity of Nrk1, the 2 carbon of adenine is solvent exposed such that the 2 amino group of guanine would not appear to preclude binding in the same manner. However, in the ATP-specific Nrk2 sequence, Glu174 is replaced with Arg. Indeed, in a large study of amino acid propensity in adenine and guanine-binding sites, Arg was found to be localized at adenine sites and to be largely excluded from guanine sites [31].
###end p 23
###begin title 24
Nucleoside and Nucleotide Recognition by Nrk1
###end title 24
###begin p 25
###xml 107 115 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g001">Figure 1</xref>
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Stereo diagrams of Nrk1 are provided in a consistent orientation using the main chain backbone colors from Figure 1A. (A) ADP*Mg2 product complex with the corresponding difference electron density map, contoured at 3.0 A. (B) NR substrate complex. (C) Bisubstrate analog complex of AppNHp*Mg2 plus NR. (D) NMN product complex.
###end p 25
###begin p 26
###xml 112 114 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b032">32</xref>
###xml 566 574 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
To determine the nature of nucleoside phosphorylation by Nrk1, we co-crystallized the Nrk1 enzyme with NR, NR.Mg2+.AppNHp, NMN, and tiazofurin, and performed molecular replacement and refinement to obtain high-resolution models. Despite the typical hinge motions identified in Rossmann fold-containing metabolite kinases upon substrate-binding [32], Nrk1 was neither opened nor closed by any ligands examined. Pairwise comparisons of the alpha carbon coordinates indicated that all structures are within a root mean square difference of less than 0.4 A. As shown in Figure 2B, which is derived from a 1.32-A crystal structure, NR is bound with the 2' and 3' hydroxyl groups recognized by bidentate interactions from Asp56 and Arg129 and with the carboxylate of Asp36 accepting an apparent hydrogen bond from the NR 5' hydroxyl. Such a hydrogen bond could serve to activate the 5' oxygen toward bond formation with the gamma phosphorous atom of a bound ATP substrate.
###end p 26
###begin p 27
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
###xml 130 132 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 350 352 346 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 389 397 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
As shown in Figure 2C, in the 1.92-A refined crystal structure of Nrk1 bound to the hydrolysis-resistant ATP analog AppNHp with Mg2+ and NR, the gamma phosphate-recognized by side chains of Thr12, Lys16, Tyr134, and Arg132-is positioned for potential in-line transfer to the 5' oxygen of NR. In this structure, the carboxylate of Asp36 is a direct Mg2+ ligand. In the NMN product complex (Figure 2D), all four side chains "formerly" associated with the gamma phosphate of AppNHp are associated with the alpha phosphate of NMN, suggesting that these residues may be optimally aligned to stabilize a putative pentacoordinate phosphorane transition state that is resolved either by collapse to ATP + NR or by the formation of ADP + NMN products.
###end p 27
###begin title 28
Essential Carboxylates at the Nrk1 and Nrk2 Active Sites
###end title 28
###begin p 29
###xml 11 19 11 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
###xml 31 39 31 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
###xml 266 274 266 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
###xml 299 301 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 427 435 427 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g002">Figure 2</xref>
###xml 526 528 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 658 690 658 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1-D36A, nrk1-E98A, nrk2-D35A,</italic>
###xml 695 705 695 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk2-E100A</italic>
###xml 774 778 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK1</italic>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK2</italic>
###xml 847 850 847 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK</italic>
###xml 883 887 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 902 906 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK1</italic>
###xml 960 964 960 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QNS1</italic>
###xml 988 992 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 1031 1034 1031 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK</italic>
###xml 1107 1111 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QNS1</italic>
###xml 1133 1137 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3</italic>
###xml 1195 1196 1194 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 1211 1219 1210 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g003">Figure 3</xref>
###xml 1520 1527 1519 1526 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 1541 1550 1540 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pbio-0050263-sg001">Figure S1</xref>
###xml 652 657 <span type="species:ncbi:9606">human</span>
###xml 732 737 <span type="species:ncbi:4932">yeast</span>
###xml 819 824 <span type="species:ncbi:4932">yeast</span>
###xml 1049 1054 <span type="species:ncbi:4932">yeast</span>
###xml 1520 1527 <span type="species:ncbi:562">E. coli</span>
In the NR (Figure 2B) and NMN (Figure 2D) substrate and product complexes, Asp36 is oriented toward the 5'' oxygen, suggesting a role in activating the acceptor oxygen and promoting bond formation. In the absence of NR or NMN and in the presence of the ADP product (Figure 2A), Asp36 stabilizes a Mg2+-associated water molecule. Curiously, Asp36 has yet a third unique conformation in the inactive bi-substrate analog complex (Figure 2C). In addition, Glu98 appears to have a key role in organizing a stable water ligand of Mg2+. To test the hypothesis that Asp36 and Glu98 (residues 35 and 100 in Nrk2) might be essential for function, we constructed human nrk1-D36A, nrk1-E98A, nrk2-D35A, and nrk2-E100A alleles for evaluation in yeast. These mutants, alongside wild-type NRK1 and NRK2 controls, were introduced into yeast strain BY278 in which NRK alleles were expressed from the GAL1 promoter on a LEU2 plasmid, the endogenous NRK1 gene was deleted, and a QNS1 gene was provided on a URA3 plasmid. In this system, a functional NRK gene allows a yeast cell grown in the presence of 10 muM NR to lose the QNS1 gene with associated URA3 marker, as scored by resistance to 5-fluoro-orotic acid [4]. As shown in Figure 3, the conserved Asp and Glu residues are required for function of Nrk enzymes in vivo. To exclude the possibility that the conserved Glu residues are required for folding and are potentially dispensable after protein biosynthesis, we expressed and purified nrk1-E98A and nrk2-E100A mutant proteins in E. coli. As shown in Figure S1, the conserved Glu is not required for soluble expression, accumulation, purification, or concentration. Although nrk1-E98A and nrk2-E100A proteins behaved precisely as did wild-type enzymes in purification, their activity in ATP-dependent phosphorylation of NR was below the level of detection of our assay. Thus, Asp36 (Asp35 in Nrk2) and Glu98 (Glu100 in Nrk2) are essential residues for function in vivo. The demonstrated post-biosynthetic role for the conserved Glu and the conserved active-site positions of Glu and Asp strongly argue for roles in catalysis.
###end p 29
###begin title 30
Active Site Requirement of Nrk1 and Nrk2
###end title 30
###begin p 31
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:4932">yeast</span>
The conserved carboxylates of human Nrk1, Asp36 and Glu98, and the corresponding carboxylates of Nrk2 are required for biological activity in yeast.
###end p 31
###begin title 32
Base Recognition in the Nrk1 Nucleoside-Binding Site Excludes Uridine but Supports NaR Phosphorylation
###end title 32
###begin p 33
###xml 8 15 8 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 537 540 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 873 881 873 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g004">Figure 4</xref>
Data in Table 1 show that Nrk1 has strong specificity for nucleosides containing a carboxamide group two bond lengths away from N1, such as NR and tiazofurin, and features that may discriminate against the 2- and/or 4-substitutions found in cytidine and uridine. Indeed, in crystal structures of Nrk1 bound to NR and NMN, it is clear that the 4-amino group of cytidine or the 4-oxy group of uridine could not be accommodated without rearrangement, because these constituents would clash with the carbonyl oxygen of Gln135, which is in a cis peptide linkage with Pro136. This unique backbone conformation is unlikely to be conserved by the uridine-accepting Nrk2 enzyme, which has a Thr-Val sequence in this position, likely to be in the typical trans conformation. The van der Waals clash between a modeled 4-oxy group of uridine and the Gln135 carbonyl oxygen is shown in Figure 4.
###end p 33
###begin title 34
NR/Uridine Discrimination by Nrk1
###end title 34
###begin p 35
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
In stereo, the 2- and 4-oxy functions (black) of a hypothetical uridine substrate are shown superimposed onto NR coordinates in the Nrk1 NR co-crystal structure. At a distance of 2.55 A, the 4 oxygen would be in van der Waals conflict with the carbonyl oxygen of Gln135, which is in a cis peptide linkage with Pro136.
###end p 35
###begin p 36
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g005">Figure 5</xref>
###xml 446 454 446 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g005">Figure 5</xref>
###xml 948 955 948 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 1136 1137 1136 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1137 1138 1137 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 1167 1168 1167 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1168 1171 1168 1171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 1190 1191 1190 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 1191 1194 1191 1194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cat</sub>
###xml 1195 1196 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1196 1197 1196 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 1089 1094 <span type="species:ncbi:9606">human</span>
###xml 1294 1299 <span type="species:ncbi:9606">human</span>
###xml 1309 1314 <span type="species:ncbi:9606">human</span>
The carboxamide-containing preferred nucleoside substrates of Nrk1 are tiazofurin and NR. As shown in Figure 5A, the two nucleosides are bound almost superimposably by Nrk1. The pyridine and thiazole moieties of NR and tiazofurin, respectively, are stacked between the phenol rings of Tyr55 and Tyr134. An additional aromatic interaction with Phe39 allows the polar carbonyl oxygen and amino groups of NR and tiazofurin to be exposed to solvent (Figure 5B). Because carbonyl oxygen and amino groups are isosteric at 1.9-A resolution, we looked for an electrostatic interaction that might uniquely orient the carboxamide function of NR and tiazofurin, and found no interacting residue within hydrogen-bonding distance. We therefore considered the possibility that Nrk enzymes might phosphorylate the isosteric but nonisoelectronic NR analog, NaR. Consequently, NaR was synthesized and examined as an in vitro substrate of Nrk1 and Nrk2. As shown in Table 1, NaR is phosphorylated by Nrk1 and Nrk2 with highly similar kinetics with respect to those for NR phosphorylation. In assays of each human enzyme, NaR is favored over NR by slight KM advantages offset by slight kcat disadvantages. In kcat/KM terms, Nrk1 has 60% of the activity and Nrk2 has 138% of the activity with NaR versus NR. Thus, human Nrk1 and human Nrk2 are dual-specificity, NR and NaR kinases.
###end p 36
###begin title 37
NR and Tiazofurin Recognition by Nrk1
###end title 37
###begin p 38
(A) Coordinates of tiazofurin, in yellow, are superimposed with those of NR in isomorphous crystal structures. The sulfur atom of tiazofurin was localized by the 3 A anomalous difference Fourier map, contoured in purple at 2.7 A. (B) A surface representation of the Nam binding-site of NR reveals no specific recognition of the carboxamide group, which is exposed to solvent.
###end p 38
###begin title 39
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
NaR Is a Novel NAD+ Precursor Utilized via the Nrk and Preiss-Hander Pathways
###end title 39
###begin p 40
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 662 670 662 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">6</xref>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b033">33</xref>
###xml 903 904 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 963 964 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 983 985 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b021">21</xref>
###xml 1002 1010 1001 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 1024 1028 1023 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 1108 1110 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1202 1206 1201 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 1432 1441 1431 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 nrk1</italic>
###xml 1551 1559 1550 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g007">Figure 7</xref>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 203 208 <span type="species:ncbi:4932">yeast</span>
###xml 568 573 <span type="species:ncbi:4932">yeast</span>
The steric complementarity of Nrk1 with NR and the lack of electrostatic exclusion of NaR by human Nrk1 and Nrk2 suggested that NaR might be a synthetic NAD+ precursor vitamin. Should NaR be utilized by yeast cells, it would be conceivable that NaR is a previously unrecognized metabolite, such that the utility of NaR salvage might have played a role in the evolution of Nrk specificity. Additionally, our discovery of Nrk1-dependent [4] and Nrk1-independent [15] NR utilization suggested that, should NaR support the vitamin requirement of de novo pathway-deficient yeast cells, there could be two different metabolic pathways for NaR utilization. As shown in Figure 6A and 6B, the bna1 mutant in de novo biosynthetic enzyme 3-hydroxyanthranilic acid dioxygenase is a Na auxotroph [33] that can also be supported by 10 muM NR, thus providing an assay for vitamin activity of NaR. As reported earlier [4], NR can bypass the requirement of glutamine-dependent NAD+ synthetase, Qns1 [21]. Also shown in Figure 6B, NR keeps a bna1 mutant alive in two different ways because cells have two NR salvage pathways [15]. The first NR salvage pathway goes through Nrk1, which allows NR-dependent viability in a bna1 mutant deleted for Npt1, which is the Na phosphoribosyltransferase. The second NR salvage pathway depends on the NR-splitting activities of Urh1 and Pnp1, followed by nicotinamidase and Npt1 activities. This pathway allows a bna1 nrk1 double mutant to retain viability. The two NR salvage pathways are schematized in the lower right section of Figure 7.
###end p 40
###begin title 41
NaR Utilization In Vivo
###end title 41
###begin p 42
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qns1</italic>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 143 152 143 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 nrk1</italic>
###xml 154 163 154 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 npt1</italic>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and qns1</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 527 531 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qns1</italic>
###xml 562 563 562 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 619 628 619 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">urh1 pnp1</italic>
###xml 634 648 634 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1 urh1 pnp1</italic>
###xml 792 806 791 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1 urh1 pnp1</italic>
###xml 884 885 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In (A), the vitamin requirement of de novo mutant bna1 and glutamine-dependent NAD+ synthetase mutant qns1 is illustrated. The fact that bna1, bna1 nrk1, bna1 npt1, and qns1 strains are satisfied by addition of NR is shown in (B). In (C), the vitamin activity of NaR is demonstrated for the de novo mutant bna1, even when either the Nrk pathway or the Preiss-Handler pathway is mutationally inactivated by nrk1 or npt1 mutation, respectively. Establishing the uniqueness of NaR as a vitamin, NaR fails to support the growth of qns1. In (D), the intracellular NAD+ concentration is calculated for wild-type, npt1, nrk1, urh1 pnp1, and nrk1 urh1 pnp1 mutants in vitamin-free (gray bars) and in vitamin-free media supplemented with 10 muM NaR (black bars). The unique lack of utilization by the nrk1 urh1 pnp1 strain shows that NaR makes use of Nrk1, Urh1, and Pnp1 for conversion to NAD+.
###end p 42
###begin title 43
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 19 24 <span type="species:ncbi:4932">Yeast</span>
NAD+ Metabolism in Yeast: Two New Pathways to NaMN
###end title 43
###begin p 44
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
Previously reported NAD+ metabolic pathways are shown in black[15]. In blue and green, respectively, are Nrk1-dependent and Nrk1-independent routes from NaR to NaMN.
###end p 44
###begin p 45
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 54 58 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 112 113 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 157 158 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 411 420 410 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 npt1</italic>
###xml 464 472 463 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 520 529 519 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 npt1</italic>
###xml 683 687 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qns1</italic>
###xml 708 716 707 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 758 762 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qns1</italic>
###xml 828 837 827 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 npt1</italic>
###xml 842 851 841 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 nrk1</italic>
###xml 1041 1049 1040 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g007">Figure 7</xref>
###xml 179 184 <span type="species:ncbi:4932">yeast</span>
###xml 537 542 <span type="species:ncbi:4932">yeast</span>
As shown in Figure 6C, 10 muM NaR can also be used by bna1 mutants, establishing that NaR is a transportable NAD+ precursor vitamin. Genetic control over NAD+ biosynthesis in the yeast system allowed us to establish that NaR is not simply used as Na, not contaminated by or converted to NR, and is used via a unique set of enzymes including Nrk1, Urh1 and Pnp1, and Qns1. If NaR were merely a source of Na, the bna1 npt1 mutant would fail to grow on NaR. However, Figure 6C clearly shows that NaR supports the growth of bna1 npt1 mutant yeast cells. Moreover, if NaR were either contaminated by NR or converted to NR by any cellular process, then NaR would support the growth of the qns1 mutant. As shown in Figure 6C, NaR fails to support the growth of the qns1 mutant. Whereas NaR shares with NR the ability to be utilized by bna1 npt1 and bna1 nrk1 mutants, the Qns1 requirement for NaR indicates that NaR metabolites must flow through nicotinic acid mononucleotide (NaMN) and nicotinic acid adenine dinucleotide (NaAD) as schematized in Figure 7.
###end p 45
###begin p 46
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 npt1</italic>
###xml 41 50 41 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 nrk1</italic>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b034">34</xref>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b007">7</xref>
###xml 595 600 <span type="species:ncbi:4932">yeast</span>
Vitamin activity of NaR in bna1 npt1 and bna1 nrk1 mutant strains can be explained by two pathways for NaR utilization. NaR is phosphorylated by Nrk1 with highly similar kinetics to those of NR (Table 1). Thus, phosphorylation of NaR by Nrk1 produces NaMN in a pathway that is independent of Npt1. By analogy with the recently described Nrk1-independent NR utilization pathway, we hypothesized that NaR is a substrate of the nucleoside hydrolase and nucleoside phosphorylase activities of Urh1 and Pnp1, which are responsible for virtually all Nrk1-independent NR salvage [15]. However, whereas yeast Nrk1-independent NR salvage requires nicotinamidase, the corresponding pathway for NaR would simply produce Na from NaR, which would be salvaged by the Preiss-Handler pathway [34], consisting of Na phosphoribosyltransferase Npt1 [7], Nma1,2, and Qns1.
###end p 46
###begin p 47
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 176 185 176 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">urh1 pnp1</italic>
###xml 198 212 198 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1 urh1 pnp1</italic>
###xml 316 324 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 343 344 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 378 392 377 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1 urh1 pnp1</italic>
###xml 456 457 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 592 593 586 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 652 654 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 769 770 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 779 783 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 795 796 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 864 865 853 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 928 937 913 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">urh1 pnp1</italic>
###xml 977 981 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 1039 1040 1022 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1083 1084 1066 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b007">7</xref>
###xml 1095 1109 1078 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1 urh1 pnp1</italic>
###xml 1187 1189 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1209 1210 1190 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1351 1355 1330 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 1494 1495 1471 1472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
To test the hypothesis that NaR utilization depends on Nrk1, Urh1, and Pnp1, i.e., the same enzymes that initiate NR salvage [15], we grew wild-type, npt1 mutant, nrk1 mutant, urh1 pnp1 mutant, and nrk1 urh1 pnp1 mutant cells in vitamin-free media and in vitamin-free media supplemented with 10 muM NaR. As shown in Figure 6D, NaR elevates NAD+ levels in all strains except the nrk1 urh1 pnp1 mutant. In the wild-type strain, NaR elevated intracellular NAD+ from 0.70 +/- 0.04 mM to 1.18 +/- 0.10 mM, an increase of 480 muM. This can be compared with the 1.21 mM increase in intracellular NAD+ that is produced by growing wild-type cells in 10 muM NR [15]. Elimination of Nrk1 or both Urh1 and Pnp1 produced an identical 40% decline in the ability of NaR to elevate NAD+. In the nrk1 mutant, NAD+ was elevated from 0.70 +/- 0.03 mM to 0.99 +/- 0.05 mM, whereas NAD+ was elevated from 0.70 +/- 0.01 mM to 0.99 +/- 0.02 mM in the urh1 pnp1 double mutant. Two strains, namely the npt1 mutant (0.59 +/- 0.001 mM), which is deficient in the NAD+ salvage necessitated by Sirtuin activity [7], and the nrk1 urh1 pnp1 mutant (0.60 +/- 0.02 mM), which is deficient in NR utilization and salvage [15], have baseline NAD+ concentrations in vitamin-free media that are 110 muM and 100 muM lower than those of the other strains, respectively. However, whereas the npt1 mutant was increased to 0.73 +/- 0.03 mM with addition of NaR, the triple mutant in NR utilization was unable to obtain an increase in NAD+ concentration in response to NaR (0.59 +/- 0.02 mM).
###end p 47
###begin p 48
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 99 106 99 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 130 138 130 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 271 280 271 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 nrk1</italic>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 518 519 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 596 604 596 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g007">Figure 7</xref>
###xml 509 514 <span type="species:ncbi:4932">Yeast</span>
Thus, NaR is a synthetic vitamin precursor of NAD+ that is phosphorylated by Nrk enzymes in vitro (Table 1) and utilized in vivo (Figure 6). In vivo utilization of NaR is not limited to the Nrk pathway producing NaMN, because NaR can fulfill the vitamin requirement of a bna1 nrk1 mutant, and NaR can elevate NAD+ in cells without Nrk1. Just as NR salvage goes through Nrk and Urh1/Pnp1 pathways [15], the nucleoside-splitting activities of Urh1 and Pnp1 and Nrk1 must be eliminated to block NaR utilization. Yeast NAD+ biosynthetic pathways updated to include NaR utilization are schematized in Figure 7.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
The experiments performed herein establish that Asp36 and Glu98 have essential roles in Nrk function. Structures of Nrk1 bound to adenosine nucleotides and pyridine and thiazol nucleoside substrates provided information of the basis for ATP/GTP nondiscrimination and pyrimidine exclusion by Nrk1. Structural analysis of Nrk2 is expected to shed light on how Nrk2 excludes GTP and phosphorylates uridine.
###end p 50
###begin p 51
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 587 595 587 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g004">Figure 4</xref>
###xml 666 674 666 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g005">Figure 5</xref>
###xml 876 883 876 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t001">Table 1</xref>
###xml 1061 1062 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1136 1144 1136 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 1164 1172 1164 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g007">Figure 7</xref>
###xml 1463 1464 1463 1464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1477 1478 1477 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 1633 1635 1633 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1739 1740 1739 1740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 32 37 <span type="species:ncbi:4932">yeast</span>
###xml 1025 1030 <span type="species:ncbi:4932">yeast</span>
###xml 1356 1361 <span type="species:ncbi:4932">yeast</span>
It has been established that no yeast enzyme can substitute for Nrk1 in conversion of NR to NMN in vivo [4]. Moreover, the postulated role for Nrk enzymes in phosphorylating NR-mimetic prodrugs has created expectations for strong specificity in carboxamide recognition. Structures of Nrk1 with NR and tiazofurin, however, indicated that the nucleosides are recognized by polar interactions with the 2', 3', and 5' hydroxyl groups and aromatic interactions with the base. Whereas there are steric clashes that would appear to destabilize the 4-substitutions found in cytosine and uracil (Figure 4), there is steric complementarity for the 3 carboxamide moiety in NR (Figure 5B). Recognizing the absence of an enzyme feature that would specifically orient the carboxamide group, we synthesized NaR and discovered that both Nrk1 and Nrk2 are dual-specificity NR and NaR kinases (Table 1). To determine whether this specificity is merely a biochemical curiosity or might indicate another cellular function, we determined whether yeast cells deficient in de novo NAD+ biosynthesis can use NaR in vivo. According to genetic data presented in Figure 6 and schematized in Figure 7, NaR is used via Na salvage and via Nrk1-dependent production of NaMN. The Nrk-dependent and Nrk-independent salvage of NaR is precedented by the processes by which NR is utilized in yeast cells. NR is utilized in an Nrk-dependent process that does not depend on the glutamine-dependent NAD+ synthetase [4]. However, NR is also utilized in a process that depends on NR splitting by Urh1, Pnp1 and Meu1, the Pnc1 nicotinamidase, and the Preiss-Handler pathway [15]. The unique feature of NaR as an in vivo substrate of the Nrk pathway is that NaR requires Nrk and NAD+ synthetase.
###end p 51
###begin p 52
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b035">35</xref>
The importance of the dual specificity of Nrk enzymes at phosphorylating NR and NaR is three-fold. First, there are active programs to design prodrugs of NAD+-antagonistic compounds such as TAD and benzamidine adenine dinucleotide. It has been assumed that such prodrugs must not stray far from NR to allow phosphorylation, adenylylation, and inhibition of the target dehydrogenases [35]. However, the discovery that Nrk1 and, apparently, Nrk2 exhibit steric but not electrostatic recognition of the carboxamide group will allow a wider range of prodrugs to be synthesized and evaluated.
###end p 52
###begin p 53
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 594 595 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Second, the abilities of yeast to use NaR and of human Nrk enzymes to phosphorylate NaR in vitro suggest that NaR might be useful as a vitamin precursor to NAD+. However, because Nrk-independent salvage requires expression of all three Preiss-Handler enzymes, Nrk-independent utilization of NaR would amount to supplementing with a very expensive form of Na. This is impractical because Na is already readily available in the diet and may be tissue-limited by the expression of Na phosphoribosyltransferase. Because maturation of NaR to NAD+ through the Nrk pathway requires the activity of NAD+ synthetase, NaR might be more tissue-restricted than NR or constitute a slower-release niacin-equivalent than NR. Thus, it is conceivable that NaR could be a useful supplement, particularly if it largely evades Nrk-independent phosphorolysis to Na or, as suggested for NR [15], if NaR phosphorolysis can be inhibited, presumably with a Pnp inhibitor.
###end p 53
###begin p 54
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qns1</italic>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b016">16</xref>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 822 823 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 853 857 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK1</italic>
###xml 859 863 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URH1</italic>
###xml 869 873 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PNP1</italic>
###xml 1057 1058 1057 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1131 1133 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1237 1238 1237 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1256 1260 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 1265 1279 1265 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1 urh1 pnp1</italic>
###xml 1328 1329 1328 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1360 1368 1360 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0050263-g006">Figure 6</xref>
###xml 1403 1404 1403 1404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1498 1499 1498 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 76 <span type="species:ncbi:4932">yeast</span>
###xml 390 395 <span type="species:ncbi:4932">yeast</span>
###xml 512 518 <span type="species:ncbi:10090">murine</span>
###xml 561 566 <span type="species:ncbi:4932">yeast</span>
###xml 686 691 <span type="species:ncbi:4932">yeast</span>
Finally, the biotransformation of NaR by the two NR salvage systems in yeast prompts us to ask whether NaR might be an endogenous metabolite, such that the utility of NaR phosphorylation could have played a role in maintaining dual NR/NaR substrate specificity. NR was initially characterized as a compound produced in the laboratory and found in milk that can provide for qns1-independent yeast cell growth when added exogenously [4]. Exogenously applied NR protects against transection-induced degeneration of murine dorsal root ganglion neurons [16]. In the yeast system, exogenously applied NR increases NAD+ levels, Sir2 function, and replicative life span [15]. Additionally, the yeast study provided evidence for an endogenous NAD+ catabolic process that creates a requirement for NR salvage enzymes to maintain NAD+ levels [15]. By deleting the NRK1, URH1, and PNP1 genes, which account for virtually all NR utilization through both the Nrk-dependent and the Nrk-independent pathways, we showed that there is a significant (0.8 mM) deficiency in NAD+ levels in cells grown in standard media, which does not contain any NR [15]. These data strongly argue for an endogenous process that produces NR and/or NaR at the expense of NAD+. Indeed, because npt1 and nrk1 urh1 pnp1 mutants have the same deficiency in baseline NAD+ levels in vitamin-free media (Figure 6D), we suggest that the rate of NAD+ catabolism to NR and/or NaR is comparable to the rate of Sirtuin-dependent consumption of NAD+ to Nam.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
Enzyme purification and characterization.
###end title 56
###begin p 57
###xml 73 80 73 80 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 564 565 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 73 80 <span type="species:ncbi:562">E. coli</span>
His-tagged human Nrk1 and Nrk2 proteins were expressed and purified from E. coli strain BL21(DE3) as described [4]. Kinetic analyses were performed in 20 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2 with 1 mM ATP or GTP as phosphodonor and with varying concentrations of nucleoside substrates. Reactions were initiated by Nrk1 or Nrk2 enzyme sufficient to convert 1% to 10% of the input nucleoside to nucleoside monophosphate in 30 min incubations at 37 degreesC. Products were quantified by anion exchange high-performance liquid chromatography (HPLC) as described [4] and kinetic parameters were determined from Lineweaver-Burke plots.
###end p 57
###begin title 58
Crystallization, structure determination, and refinement.
###end title 58
###begin p 59
###xml 125 132 119 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t002">Table 2</xref>
###xml 214 221 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t002">Table 2</xref>
###xml 275 277 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b036">36</xref>
###xml 364 366 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b037">37</xref>
###xml 409 411 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b038">38</xref>
###xml 564 566 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b039">39</xref>
###xml 605 607 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b040">40</xref>
###xml 649 651 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b041">41</xref>
###xml 688 690 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b042">42</xref>
###xml 738 745 732 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0050263-t002">Table 2</xref>
###xml 818 820 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b043">43</xref>
###xml 880 882 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b039">39</xref>
Nrk1 (30 mg/ml) was crystallized by 1:1 sitting drop vapor diffusion (18 degreesC) against the reservoir solutions listed in Table 2. Crystals were cryo-protected in 1:1 paratone and mineral oil. Diffraction data (Table 2) were reduced to intensities with the HKL2000 suite [36], and the first Nrk1 structure was solved de novo as described in the text. ARP/wARP [37] was used for model building, and PHASER [38] was used for molecular replacement of subsequent Nrk1 structures. Geometric restrains for NR, NMN, and tiazofurin were generated on the PRODRG server [39]. Restrained refinement using REFMAC [40], geometric validation using MOLPROBITY [41], and manual rebuilding using COOT [42] were performed iteratively until convergence (Table 2). Coordinate alignments were performed by secondary structure matching [43] within COOT. Molecular graphics were produced with PyMOL [39]. Structure factors and coordinates have been deposited in the Protein Data Bank.
###end p 59
###begin title 60
Synthesis of NaR.
###end title 60
###begin p 61
###xml 358 359 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 361 362 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 406 407 403 404 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 409 410 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1413 1414 1394 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1415 1416 1396 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1435 1436 1416 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1437 1438 1418 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1525 1526 1506 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1527 1528 1508 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1686 1688 1667 1669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1717 1719 1698 1700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 161 166 <span type="species:ncbi:42554">tetra</span>
###xml 1141 1144 <span type="species:ncbi:9823">pig</span>
Trimethylsilyl trifluoromethanesulfonate (1.039 g, 4.4 mmol; Sigma-Aldrich; ) was slowly added to ethyl nicotinate (0.9 ml, 6.6 mmol; Sigma-Aldrich) and 1,2,3,5-tetra-O-acetyl-beta-D-ribofuranose (1.4 g, 4.4 mmol; Sigma-Aldrich) in 50 ml anhydrous methylene chloride at room temperature, stirred under argon. The mixture was heated to reflux for 8 h. TLC (CH2Cl2: MeOH: TEA=5: 0.3: 0.05) stained with 10% H2SO4 in MeOH showed the disappearance of the ribofuranose and appearance of the presumed product, 2', 3', 5'-triacetyl ethyl NaR in a single spot at lower mobility relative to the front. After evaporation of methylene chloride, product (25 mg, 0.05 mmol) was added into 0.9 ml of 312 mM NaOEt in EtOH on ice to form O-ethyl beta-NaR. After mixing well, the reaction was stored at -20 degreesC overnight. The reaction was quenched with addition of acetic acid to neutralize the pH. After organic solvent was removed in vacuum, the residue was dissolved in water and extracted with cyclohexane to remove organic impurities. The aqueous phase was then concentrated 10-fold, made to 150 mM in phosphate buffer, and provided with 10 mul of pig liver esterase (13 units; Sigma-Aldrich) to release NaR in a 25 degreesC overnight incubation. NaR was purified by C-18 HPLC. NaR was assayed by MALDI MS, in positive ion detection mode, and was observed as the protonated molecular ion (predicted mass-to-charge ratio m/z= 256.08, observed m/z= 256.1). Other assignable fragmented ions detected included protonated Na. The entire m/z spectrum (% peak height) was 256.1 (1.81%), 228.0 (48.5%), 207.1 (25.4%), 146.1 (10.3%), and 124.0 (13.9%). We used a molar extinction coefficient of 6411 cm-1 (260 nm) for NaR and 4305 cm-1 (259 nm) for NR.
###end p 61
###begin title 62
###xml 0 13 0 13 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 0 13 <span type="species:ncbi:4932">S. cerevisiae</span>
S. cerevisiae strains, plasmids, and media.
###end title 62
###begin p 63
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qns1</italic>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(QNS1</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URA3)</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LEU2</italic>
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK1</italic>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK2</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 330 339 330 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1-D36A</italic>
###xml 349 358 349 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1-E98A</italic>
###xml 368 377 368 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk2-D35A</italic>
###xml 391 401 391 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk2-E100A</italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAL1</italic>
###xml 624 625 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 652 655 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK</italic>
###xml 726 732 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(qns1)</italic>
###xml 734 735 733 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b004">4</xref>
###xml 745 749 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1</italic>
###xml 789 791 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b044">44</xref>
###xml 802 806 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 839 848 838 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bna1 npt1</italic>
###xml 1068 1070 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1285 1286 1275 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1329 1331 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1467 1473 1456 1462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600 nm</sub>
###xml 1518 1522 1507 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nrk1</italic>
###xml 1562 1564 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b044">44</xref>
###xml 1575 1579 1564 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">npt1</italic>
###xml 1619 1621 1608 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b044">44</xref>
###xml 1633 1642 1622 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">urh1 pnp1</italic>
###xml 1644 1646 1633 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 1661 1675 1650 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">urh1 pnp1 nrk1</italic>
###xml 1677 1679 1666 1668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0050263-b015">15</xref>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 1347 1352 <span type="species:ncbi:4932">yeast</span>
Yeast strain BY278, which contains qns1 deletion covered by plasmid pB175 (QNS1 and URA3) and which contains nrk1 deletion, has been described [4]. pB450 and pB459, which are LEU2 plasmids for expression of human NRK1 and NRK2 cDNAs under GAL1 promoter control [4], were used as templates for site-directed mutagenesis to produce nrk1-D36A (pHC12), nrk1-E98A (pHC10), nrk2-D35A (pHC13), and nrk2-E100A (pHC11). BY278 was transformed with each plasmid and the empty p425GAL1 control. After passage on galactose media, transformants were streaked on synthetic complete, galactose media with 5-fluoroorotic acid and 10 muM NR [4] to score the function of NRK alleles. Isogenic strains for the NaR utilization study were BY165-1d (qns1) [4], KB046 (bna1 in the deletion consortium background [44]), KB056 (nrk1 deleted from KB046), and JS949 (bna1 npt1, a gift of Jeffrey S. Smith, University of Virginia, United States). The four strains were grown in synthetic media with 3 muM Na plus 10 muM NR, washed in saline, and then cultured to exhaustion in vitamin-free media [15]. To assay utilization of NR or NaR, strains grown to exhaustion in vitamin-free media were streaked on vitamin-free synthetic media supplemented with 10 muM NR or NaR and photographed after 3 d at 28 degreesC. NAD+ measurements were performed as described [15] with isogenic yeast strains grown in vitamin-free media and vitamin-free media supplemented with 10 muM NaR to an optical density (OD)600 nm of 1. Strains were wild-type BY4742, KB009 (nrk1 in the deletion consortium background [44]), KB008 (npt1 in the deletion consortium background [44]), PAB047 (urh1 pnp1 [15]) and PAB038 (urh1 pnp1 nrk1 [15]).
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin title 65
Expression and Activity Analysis of Nrk Active-Site Glutamate Mutants
###end title 65
###begin p 66
###xml 96 103 96 103 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 96 103 <span type="species:ncbi:562">E. coli</span>
His-tagged human wild-type Nrk1 and Nrk2 and glutamate mutants were expressed and purified from E. coli by immobilized cobalt affinity chromatography. The expression and purification of wild-type Nrk2 and Nrk2-E100A were analyzed by SDS-PAGE. Both Nrk2 and Nrk2-E100A exhibited high-level overexpression in the total cell lysate and virtually identical behavior upon chromatography. Relative specific activities were calculated for Nrk1, Nrk1-E98A, Nrk2, and Nrk2-E100A. Reactions contained 1 mM ATP as phosphodonor and 1 mM NR as nucleoside acceptor. Reactions were incubated for 30 min at 37 degreesC. NMN was quantified by anion exchange HPLC.
###end p 66
###begin p 67
(74 KB DOC)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin title 69
Accession Numbers
###end title 69
###begin p 70
###xml 171 184 171 184 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 200 213 200 213 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 229 242 229 242 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 258 271 258 271 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 287 300 287 300 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 316 329 316 329 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 345 358 345 358 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 374 387 374 387 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 403 410 403 410 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 426 433 426 433 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 453 474 453 474 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">B. stearothermophilus</named-content>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 171 184 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 200 213 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 229 242 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 258 271 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 287 300 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 316 329 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 345 358 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 374 387 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 403 410 <span type="species:ncbi:562">E. coli</span>
###xml 426 433 <span type="species:ncbi:562">E. coli</span>
###xml 453 474 <span type="species:ncbi:1422">B. stearothermophilus</span>
###xml 542 547 <span type="species:ncbi:9606">human</span>
###xml 595 600 <span type="species:ncbi:9606">human</span>
The Swiss-Prot () accession numbers for proteins in this paper are: human MTAP (Q13126); human Nrk1 (Q9NWW6); human Nrk2 (Q9NPI5); human NP (P00491); human Uck2 (Q9BZX2); S. cerevisiae Bna1 (P47096); S. cerevisiae Meu1 (Q07938); S. cerevisiae Npt1 (P39683); S. cerevisiae Nrk1 (P53915); S. cerevisiae Pnc1 (P53184); S. cerevisiae Pnp1 (Q05788); S. cerevisiae Qns1 (P38795); S. cerevisiae Urh1 (Q04179); E. coli gntK (P46859); E. coli panK (P0A615); and B. stearothermophilus adk (P27142). The Protein Data Bank (PDB) () accession numbers for human Nrk1 are 2QSY, 2QT1, 2QT0, 2QSZ, and 2P0E; for human Uck2 is 1UJ2.
###end p 70
###begin p 71
We thank Robert Landry, Ivona Kozieradzki and Pawel Bieganowski for technical assistance. KLB, PB, MW, and HFS contributed equally to this study.
###end p 71
###begin title 72
Abbreviations
###end title 72
###begin p 73
adenosine-5'-[(beta,gamma)-imido]triphosphate
###end p 73
###begin p 74
nicotinic acid
###end p 74
###begin p 75
nicotinic acid adenine dinucleotide
###end p 75
###begin p 76
nicotinamide
###end p 76
###begin p 77
nicotinic acid mononucleotide
###end p 77
###begin p 78
nicotinic acid riboside
###end p 78
###begin p 79
nicotinamide mononucleotide
###end p 79
###begin p 80
nicotinamide riboside
###end p 80
###begin p 81
nicotinamide riboside kinase
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
NAD(+) metabolism in health and disease
###end article-title 83
###begin article-title 84
###xml 27 31 <span type="species:ncbi:381124">corn</span>
Growth retarding effect of corn in niacin-low rations and its counteraction by tryptophan
###end article-title 84
###begin article-title 85
The isolation and identification of the anti-black tongue factor
###end article-title 85
###begin article-title 86
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRK</italic>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 141 147 <span type="species:ncbi:9606">humans</span>
Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans
###end article-title 86
###begin article-title 87
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
###end article-title 87
###begin article-title 88
Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose
###end article-title 88
###begin article-title 89
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family
###end article-title 89
###begin article-title 90
The silencing protein Sir2 and its homologs are NAD-dependent protein deacetylases
###end article-title 90
###begin article-title 91
###xml 58 63 <span type="species:ncbi:4932">yeast</span>
Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product
###end article-title 91
###begin article-title 92
###xml 78 102 78 102 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Saccharomyces cerevisiae</named-content>
###xml 78 102 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Requirement of NAD and Sir2 for life-span extension by calorie restriction in Saccharomyces cerevisiae
###end article-title 92
###begin article-title 93
###xml 53 75 53 75 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Caenorhabditis elegans</named-content>
###xml 53 75 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
###end article-title 93
###begin article-title 94
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
###end article-title 94
###begin article-title 95
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Resveratrol improves health and survival of mice on a high-calorie diet
###end article-title 95
###begin article-title 96
Resveratrol improves mitochondrial function and protects against metabolic disease by activating Sirt1 and PGC-1alpha
###end article-title 96
###begin article-title 97
Nicotinamide riboside promotes sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD(+)
###end article-title 97
###begin article-title 98
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
###end article-title 98
###begin article-title 99
Increased nuclear NAD biosynthesis and Sirt1 activation prevent axonal degeneration
###end article-title 99
###begin article-title 100
A local mechanism mediates NAD-dependent protection of axon degeneration
###end article-title 100
###begin article-title 101
###xml 66 71 <span type="species:ncbi:9606">human</span>
Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases
###end article-title 101
###begin article-title 102
###xml 48 64 48 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 48 64 <span type="species:ncbi:562">Escherichia coli</span>
Structural basis for the feedback regulation of Escherichia coli pantothenate kinase by coenzyme A
###end article-title 102
###begin article-title 103
###xml 14 15 14 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Eukaryotic NAD+ synthetase Qns1 contains an essential, obligate intramolecular thiol glutamine amidotransferase domain related to nitrilase
###end article-title 103
###begin article-title 104
Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity
###end article-title 104
###begin article-title 105
Resolution of phase ambiguity in macromolecular crystallography
###end article-title 105
###begin article-title 106
Substructure solution with SHELXD
###end article-title 106
###begin article-title 107
Macromolecular phasing with SHELE
###end article-title 107
###begin article-title 108
Dali: A network tool for protein structure comparison
###end article-title 108
###begin article-title 109
###xml 67 72 <span type="species:ncbi:9606">human</span>
Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase
###end article-title 109
###begin article-title 110
###xml 22 49 22 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Bacillus stearothermophilus</named-content>
###xml 22 49 <span type="species:ncbi:1422">Bacillus stearothermophilus</span>
Crystal structures of Bacillus stearothermophilus adenylate kinase with bound Ap5A, Mg2+ Ap5A, and Mn2+ Ap5A reveal an intermediate lid position and six coordinate octahedral geometry for bound Mg2+ and Mn2+
###end article-title 110
###begin article-title 111
Conformational changes during the catalytic cycle of gluconate kinase as revealed by x-ray crystallography
###end article-title 111
###begin article-title 112
The P-loop-A common motif in ATP- and GTP-binding proteins
###end article-title 112
###begin article-title 113
On the molecular discrimination between adenine and guanine by proteins
###end article-title 113
###begin article-title 114
Induced-fit movements in adenylate kinases
###end article-title 114
###begin article-title 115
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
The yeast gene YJR025C encodes a 3-hydroxyanthranilic acid dioxygenase and is involved in nicotinic acid biosynthesis
###end article-title 115
###begin article-title 116
Biosynthesis of diphosphopyridine nucleotide II. Enzymatic aspects
###end article-title 116
###begin article-title 117
Modulation of cytotoxicity of benzamide riboside by expression of NMN adenylyltransferase
###end article-title 117
###begin article-title 118
Processing of x-ray diffraction data collected in oscillation mode
###end article-title 118
###begin article-title 119
Automated protein model building combined with iterative structure refinement
###end article-title 119
###begin article-title 120
Likelihood-enhanced fast translation functions
###end article-title 120
###begin article-title 121
PRODRG: A tool for high-throughput crystallography of protein-ligand complexes
###end article-title 121
###begin article-title 122
Refinement of macromolecular structures by the maximum-likelihood method
###end article-title 122
###begin article-title 123
MOLPROBITY: Structure validation and all-atom contact analysis for nucleic acids and their complexes
###end article-title 123
###begin article-title 124
COOT: Model-building tools for molecular graphics
###end article-title 124
###begin article-title 125
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions
###end article-title 125
###begin article-title 126
###xml 35 48 35 48 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. cerevisiae</named-content>
###xml 35 48 <span type="species:ncbi:4932">S. cerevisiae</span>
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis
###end article-title 126
###begin p 127
currencya Current address: Department of Structural Biology, Chair of General Endocrinology, Medical University, Lodz, Poland
###end p 127
###begin p 128
currencyb Current address: American Type Culture Collection, Manassas, Virginia, United States of America
###end p 128
###begin p 129
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. CB and HWP supervised enzyme expression and purification, which was carried out by WMR, MW, HFS, and LN. WMR crystallized the enzyme. WT solved the crystal structures with HWP. PB, MW, and HFS performed mutagenesis and in vitro characterization with CB. TY performed synthesis designed by AAS. KLB demonstrated in vivo use with CB. CB coordinated the three groups and wrote the manuscript in collaboration with all contributors.
###end p 129
###begin p 130
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. Work was supported, in part, by grant DK073466 from the National Institute of Diabetes and Digestive and Kidney Diseases to AAS. Use of beamline 17-ID at the Advanced Photon Source was supported by the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago. Use of beamline 23-ID at the Advanced Photon Source was supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The Advanced Photon Source is supported by Department of Energy contracts W-31-109-Eng-38 and DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.
###end p 130
###begin p 131
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. AAS's institution has applied to patent the synthesis and use of NaR.
###end p 131

